Shattuck Labs, Inc.
Ticker(s):
STTK
Country:
Sector & Industry:
Business Overview
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company’s lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. Shattuck Labs, Inc. was incorporated in 2016 and is headquartered in Austin, Texas.
Contact & Other Information
Number of Employees:
75
Website:
500 West 5th Street
Suite 1200
Austin
,
TX
,
78701
United States
512 900 4690
No content was found.